• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子受体相关因子(TRAFs)与CD40的高亲和力相互作用需要TRAF三聚化和CD40多聚化。

High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.

作者信息

Pullen S S, Labadia M E, Ingraham R H, McWhirter S M, Everdeen D S, Alber T, Crute J J, Kehry M R

机构信息

Department of Biology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877-0368, USA.

出版信息

Biochemistry. 1999 Aug 3;38(31):10168-77. doi: 10.1021/bi9909905.

DOI:10.1021/bi9909905
PMID:10433725
Abstract

Signaling by some TNF receptor family members, including CD40, is mediated by TNF receptor-associated factors (TRAFs) that interact with receptor cytoplasmic domains following ligand-induced receptor oligomerization. Here we have defined the oligomeric structure of recombinant TRAF domains that directly interact with CD40 and quantitated the affinities of TRAF2 and TRAF3 for CD40. Biochemical and biophysical analyses demonstrated that TRAF domains of TRAF1, TRAF2, TRAF3, and TRAF6 formed homo-trimers in solution. N-terminal deletions of TRAF2 and TRAF3 defined minimal amino acid sequences necessary for trimer formation and indicated that the coiled coil TRAF-N region is required for trimerization. Consistent with the idea that TRAF trimerization is required for high-affinity interactions with CD40, monomeric TRAF-C domains bound to CD40 significantly weaker than trimeric TRAFs. In surface plasmon resonance studies, a hierarchy of affinity of trimeric TRAFs for trimeric CD40 was found to be TRAF2 > TRAF3 >> TRAF1 and TRAF6. CD40 trimerization was demonstrated to be sufficient for optimal NF-kappaB and p38 mitogen activated protein kinase activation through wild-type CD40. In contrast, a higher degree of CD40 multimerization was necessary for maximal signaling in a cell line expressing a mutated CD40 (T254A) that signaled only through TRAF6. The affinities of TRAF proteins for oligomerized receptors as well as different requirements for degree of receptor multimerization appear to contribute to the selectivity of TRAF recruitment to receptor cytoplasmic domains.

摘要

包括CD40在内的一些肿瘤坏死因子受体(TNF)家族成员的信号传导是由TNF受体相关因子(TRAFs)介导的,这些因子在配体诱导的受体寡聚化后与受体胞质结构域相互作用。在此,我们确定了与CD40直接相互作用的重组TRAF结构域的寡聚结构,并定量了TRAF2和TRAF3对CD40的亲和力。生化和生物物理分析表明,TRAF1、TRAF2、TRAF3和TRAF6的TRAF结构域在溶液中形成同源三聚体。TRAF2和TRAF3的N端缺失确定了三聚体形成所需的最小氨基酸序列,并表明卷曲螺旋TRAF-N区域是三聚化所必需的。与TRAF三聚化是与CD40高亲和力相互作用所必需的观点一致,与CD40结合的单体TRAF-C结构域的亲和力明显低于三聚体TRAFs。在表面等离子体共振研究中,发现三聚体TRAFs对三聚体CD40的亲和力等级为TRAF2 > TRAF3 >> TRAF1和TRAF6。已证明CD40三聚化足以通过野生型CD40实现最佳的核因子κB(NF-κB)和p38丝裂原活化蛋白激酶激活。相比之下,在表达仅通过TRAF6信号传导的突变型CD40(T254A)的细胞系中,最大信号传导需要更高程度的CD40多聚化。TRAF蛋白对寡聚化受体的亲和力以及对受体多聚化程度的不同要求似乎有助于TRAF募集到受体胞质结构域的选择性。

相似文献

1
High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.肿瘤坏死因子受体相关因子(TRAFs)与CD40的高亲和力相互作用需要TRAF三聚化和CD40多聚化。
Biochemistry. 1999 Aug 3;38(31):10168-77. doi: 10.1021/bi9909905.
2
CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.CD40与肿瘤坏死因子受体相关因子(TRAF)的相互作用:通过多个TRAF结合位点和TRAF异源寡聚化对CD40信号传导的调节
Biochemistry. 1998 Aug 25;37(34):11836-45. doi: 10.1021/bi981067q.
3
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.肿瘤坏死因子受体(TNFR)相关因子(TRAF)3作为一种抑制剂,通过与TRAF结合的TNFRs抑制TRAF2/5介导的非经典NF-κB途径的激活。
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2874-9. doi: 10.1073/pnas.0500187102. Epub 2005 Feb 11.
4
Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.爱泼斯坦-巴尔病毒编码的潜伏膜蛋白1(LMP1)和CD40通过涉及肿瘤坏死因子受体相关因子的核因子κB途径介导上皮细胞中白细胞介素-6的产生。
Oncogene. 1997 Jun 19;14(24):2899-916. doi: 10.1038/sj.onc.1201258.
5
Tumor necrosis factor receptor-associated factors (TRAFs).肿瘤坏死因子受体相关因子(TRAFs)
Oncogene. 2001 Oct 1;20(44):6482-91. doi: 10.1038/sj.onc.1204788.
6
Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.前沿:肿瘤坏死因子受体相关因子2(TRAF2)和TRAF3在CD40激活的B淋巴细胞分化中的相反作用
J Immunol. 1999 Jun 1;162(11):6307-11.
7
Distinct molecular mechanism for initiating TRAF6 signalling.启动TRAF6信号传导的独特分子机制。
Nature. 2002 Jul 25;418(6896):443-7. doi: 10.1038/nature00888.
8
CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.通过肿瘤坏死因子受体相关因子(TRAFs)进行的CD40信号传导。不同TRAFs的结合位点特异性及下游通路的激活。
J Biol Chem. 1999 May 14;274(20):14246-54. doi: 10.1074/jbc.274.20.14246.
9
TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.肿瘤坏死因子受体相关因子3信号传导介导人B细胞上CD40连接后p38和Jun N端激酶的激活、细胞因子分泌及免疫球蛋白产生。
J Immunol. 1998 Aug 1;161(3):1183-93.
10
Structural basis for self-association and receptor recognition of human TRAF2.人TRAF2自我缔合及受体识别的结构基础
Nature. 1999 Apr 8;398(6727):533-8. doi: 10.1038/19110.

引用本文的文献

1
Emerging therapeutics targeting tumor-associated macrophages for the treatment of solid organ cancers.靶向肿瘤相关巨噬细胞治疗实体器官癌症的新兴疗法。
Expert Opin Emerg Drugs. 2025 Jun;30(2):109-147. doi: 10.1080/14728214.2025.2504376. Epub 2025 May 25.
2
Transient Expression in HEK-293 Cells in Suspension Culture as a Rapid and Powerful Tool: SARS-CoV-2 N and Chimeric SARS-CoV-2N-CD154 Proteins as a Case Study.悬浮培养的HEK-293细胞中的瞬时表达作为一种快速且强大的工具:以SARS-CoV-2 N蛋白和嵌合SARS-CoV-2 N-CD154蛋白为例进行研究
Biomedicines. 2023 Nov 14;11(11):3050. doi: 10.3390/biomedicines11113050.
3
Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling.
控制模块化多价展示 CD40 配体于 P22 病毒样颗粒上可导致 CD40 信号的可调放大。
ACS Appl Bio Mater. 2021 Dec 20;4(12):8205-8214. doi: 10.1021/acsabm.1c00718. Epub 2021 Nov 10.
4
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint.CD40/CD40L 免疫检查点的分子基础和治疗意义。
Pharmacol Ther. 2021 Mar;219:107709. doi: 10.1016/j.pharmthera.2020.107709. Epub 2020 Oct 20.
5
Human immunoglobulin G hinge regulates agonistic anti-CD40 immunostimulatory and antitumour activities through biophysical flexibility.人免疫球蛋白 G 铰链通过生物物理灵活性调节激动性抗 CD40 免疫刺激和抗肿瘤活性。
Nat Commun. 2019 Sep 27;10(1):4206. doi: 10.1038/s41467-019-12097-6.
6
A replication-incompetent CD154/40L recombinant vaccinia virus induces direct and macrophage-mediated antitumor effects and .一种无复制能力的CD154/40L重组痘苗病毒可诱导直接的和巨噬细胞介导的抗肿瘤作用。
Oncoimmunology. 2019 Feb 14;8(5):e1568162. doi: 10.1080/2162402X.2019.1568162. eCollection 2019.
7
Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect.在癌症免疫治疗中靶向 APC 激活以增强远隔效应。
Front Immunol. 2019 Apr 2;10:604. doi: 10.3389/fimmu.2019.00604. eCollection 2019.
8
Conjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1.干眼疾病中结膜炎症基因表达谱分析:与 HLA-DRA 和 HLA-DRB1 的相关性。
Front Immunol. 2018 Oct 15;9:2271. doi: 10.3389/fimmu.2018.02271. eCollection 2018.
9
Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease.川崎病中未成熟血小板及抗血小板治疗对阿司匹林的反应
Drug Des Devel Ther. 2018 May 23;12:1353-1362. doi: 10.2147/DDDT.S163705. eCollection 2018.
10
Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.移植环境中靶向共抑制和共刺激途径的研究进展:癌症免疫治疗的阴阳两面
Immunol Rev. 2017 Mar;276(1):192-212. doi: 10.1111/imr.12523.